Location: Grange Castle, Clondalkin, Ireland
Project type: Biotech production plant
Expected Completion: 2027
Estimated Investment: $1.26 bn
Pfizer will invest more than €1.2bn ($1.26bn) to build a new facility in the site premises to double the biological drug substance manufacturing capacity of the campus. Construction work is expected to begin in 2024 and will complete in 2027.
Location: Suzhou, China
Project type: GMP cell culture media manufacturing facility
Opening date: September 2023
Eminence Biotechnology, a cell culture solutions provider based in China, opened a good manufacturing practice (GMP)-certified facility in Suzhou, China, in September 2023, to manufacture cell culture media on a commercial scale. The state-of-the-art facility covers a 7,000m² area.
Location: Castel Romano Technopole, Italy
Project type: Viral Vector Production Facility Expansion
Construction start: May 2020
Estimated investment: €15m ($14.6m)
ReiThera, a contract development and manufacturing organisation based in Italy, has expanded its viral production operations facility to meet the demand for viral vectors globally. The expansion included the construction of a specialised production area which opened in May 2020.